Want to join the conversation?
$ENDP 2Q15 Call: Our US generics business continues to deliver impressive results in the second quarter with sales of $338MM,& that contributed YTD growth of 44% versus prior year. Our YTD 2015 results primarily benefit from organic growth & number of value-creating acquisitions as well as LIDODERM AG, which was a strong source of growth as well.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!